$DTIL
Precision BioSciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$6.64
▼-0.44%-$0.029
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePrecision BioSciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is DTIL down today? It is at $6.64 (-0.44%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DTIL spikes, and full due diligence on DTIL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DTIL 10 times in the last 30 days. Create a free account to track $DTIL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DTIL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DTIL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedAug 24, 2026 · 27 days agoAcross every filing on file, supply equal to 479.6% of the tradeable float is in play - 479.6% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $250.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Germano Geno J Director | Other | 21K 0.08% of company | added 88% | 45K | n/a | May 20, 26 |
Pire Shari Lisa Director | Other | 21K 0.08% of company | added 100% | 35K | n/a | May 20, 26 |
Brown Melinda Director | Other | 21K 0.08% of company | added 90% | 44K | n/a | May 20, 26 |
Frankel Stanley Director | Other | 21K 0.08% of company | added 100% | 40K | n/a | May 20, 26 |
Buehler Kevin Director | Other | 21K 0.08% of company | added 75% | 49K | n/a | May 20, 26 |
Smith J. Jefferson Officer | Sold (automatic/other) | -5K 0.02% of company | sold 3.9% | 122K | $19K at $3.84 | Feb 18, 26 |
Kelly John Alexander Officer | Sold (automatic/other) | -8K 0.03% of company | sold 6.1% | 126K | $31K at $3.84 | Feb 18, 26 |
Scimeca Dario Officer | Sold (automatic/other) | -5K 0.02% of company | sold 8.0% | 56K | $19K at $3.84 | Feb 18, 26 |
Amoroso Michael Officer | Sold (automatic/other) | -21K 0.07% of company | sold 7.8% | 243K | $79K at $3.84 | Feb 18, 26 |
Smith J. Jefferson Officer | Other | 17K 0.06% of company | added 15% | 127K | n/a | Feb 17, 26 |
Kelly John Alexander Officer | Other | 28K 0.10% of company | added 26% | 134K | n/a | Feb 17, 26 |
Scimeca Dario Officer | Other | 17K 0.06% of company | added 37% | 61K | n/a | Feb 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on DTIL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DTIL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
DTIL last traded at $6.64, down 0.44% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Precision BioSciences, Inc. Common Stock (DTIL) is next expected to report earnings on Monday, November 2, 2026, about 43 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DTIL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DTIL 10 times in the last 30 days.
DTIL (Precision BioSciences, Inc. Common Stock) trades on XNAS, with a market cap of about $184M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DTIL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DTIL discussion
Sign in to ask a question or join the discussion.